Our Solution
Designing the future of structural heart device. Triflo has been specifically ideated and designed for Tricuspid Regurgitation.
The Tricuspid Flow Optimizer features:
Intraoperatively Customizable
Severe regurgitation reduction regardless of size or shape of the native valve to treat wider patient segments.
Safe and Durable
Safety and biocompatibility with minimalistic design, secure fixation, and adaptive mini-valve with polymer leaflets.
Ease of Use
Ease of implementation with rapid learning curve using transfemoral delivery method.
Scalable Design
Simple scale-up and favorable production process considered since inception.
The Tricuspid Flow Optimizer is in development and is not available for sale or general clinical use anywhere in the world. As a permanent heart implant, it requires extensive testing to ensure safety and efficacy for human use.